ATXN3L Polyclonal Antibody, AbBy Fluor-647 Conjugated, BF647, Rabbit

Artikelnummer: BSS-BS-4807R-BF647
Artikelname: ATXN3L Polyclonal Antibody, AbBy Fluor-647 Conjugated, BF647, Rabbit
Artikelnummer: BSS-BS-4807R-BF647
Hersteller Artikelnummer: bs-4807R-BF647
Alternativnummer: BSS-BS-4807R-BF647-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF, WB
Spezies Reaktivität: Human
Konjugation: BF647
Alternative Synonym: ATX3L_HUMAN, ATXN3L, Machado-Joseph disease protein 1-like, MJDL, Putative ataxin-3-like protein.
Defects in ATXN3 are the cause of spinocerebellar ataxia type 3 (SCA3) , also known as Machado-Joseph disease (MJD). Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATXN3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 92552
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human ATXN3L
Target-Kategorie: ATXN3L
Application Verdünnung: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)